Skip to main
RNA

RNA Market Capitalization Overview

Market Cap: $230.88M as of Apr 24, 2026

$230.88M
As of Apr 24, 2026, RNA has a market capitalization of $230.88M. Over the past 30 days, its market cap has increased by , while in the last 12 months, it has increased by .

Market capitalization represents the total value of Atrium Therapeutics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

RNA Market Cap Formula = Stock Price * Shares Outstanding

The market cap of RNAhelps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

RNA Market Cap History

DateMarket CapChange

RNA End of Year Market Cap History

DateMarket CapChange
2026$230.88M

FAQs About Atrium Therapeutics Inc (RNA) Market Cap

As of Apr 24, 2026, the market capitalization of RNA is $230.88M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Atrium Therapeutics Inc’s market capitalization has increased by —, changing from – to $230.88M as of Apr 24, 2026.

In the last 3 months, Atrium Therapeutics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year –, Atrium Therapeutics Inc’s market capitalization increased from – in January to – in December, reflecting a — change.

Atrium Therapeutics Inc (RNA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.